Patents for C12R 1 - Micro-organisms (92,025) |
---|
01/02/2001 | US6168936 Oxidase; for utilization in detergent development, papermaking and pulping, textile preparation and food processing |
01/02/2001 | US6168935 Preparation of optically active alcohol substituted with one or more halogen atoms |
01/02/2001 | US6168934 Oligosaccharide enzyme substrates and inhibitors: methods and compositions |
01/02/2001 | US6168927 Expression of G protein coupled receptors in yeast |
01/02/2001 | US6168917 Detection and identification of non-polio enteroviruses |
01/02/2001 | US6168791 Antibodies that bind immunomodulators |
01/02/2001 | US6168790 Use of antibodies to block the effects of gram-positive bacteria and mycobacteria |
01/02/2001 | US6168783 Antagonists of interleukin-15 |
01/02/2001 | CA2113203C Human calcium channel compositions and methods |
01/02/2001 | CA2035899C Chimeric anti-cea antibody |
01/02/2001 | CA2034979C Antibiotic, deoxymulundocandin, a process for its production and its useas medicament |
01/02/2001 | CA2025070C Recombinant aprotinin variants genetically engineered process for the microbial preparation of homgeneously processed aprotinin variants and the therapeutic use thereof |
01/02/2001 | CA2007336C Diagnostic test using chimeric antibodies |
01/02/2001 | CA1341160C Bovine granulocyte-macrophage colony stimulating factor |
12/29/2000 | CA2300467A1 Cancer vaccines |
12/28/2000 | WO2000078978A1 Pichia methanolica glyceraldehyde 3-phosphate dehydrogenase 1 promoter and terminator |
12/28/2000 | WO2000078972A2 Regulation with binding cassette transporter protein abc1 |
12/28/2000 | WO2000078971A2 Atp binding cassette transporter protein abc1 popypeptides |
12/28/2000 | WO2000078967A1 Avirulent xanthomonas-campestris strains producing xanthan |
12/28/2000 | WO2000078927A2 Spheroid preparation |
12/28/2000 | WO2000078925A1 Rapid growing microorganisms for biotechnology applications |
12/28/2000 | WO2000078905A1 Biotechnological method of cleaning applicable to engineering components |
12/28/2000 | WO2000078811A1 Human antithrombin variants |
12/28/2000 | WO2000078781A1 Detection of giardia |
12/28/2000 | WO2000078337A1 Compositions containing soluble forms of hla-g for treating inflammatory skin pathologies |
12/28/2000 | WO2000078322A2 Combination of lactic acid bacteria and its use for the prevention and/or treatment of infections and inflammatory conditions |
12/28/2000 | WO2000078308A1 Antibiotic compound |
12/28/2000 | WO2000063348A3 Pharmaceutical composition comprising pim-activated nkt cells, and therapeutic use thereof |
12/28/2000 | WO2000048614A3 Method for producing anti-tumor th1 cells |
12/28/2000 | WO2000017369B1 Alzheimer's disease secretase |
12/28/2000 | CA2397494A1 Pichia methanolica glyceraldehyde-3-phosphate dehydrogenase 1 promoter and terminator |
12/28/2000 | CA2376007A1 Antibiotic compound |
12/28/2000 | CA2375791A1 Avirulent xanthomonas-campestris strains producing xanthan |
12/28/2000 | CA2375781A1 Compositions and methods for increasing cholesterol efflux and raising hdl using atp binding cassette transporter protein abci |
12/28/2000 | CA2375482A1 Rapid growing microorganisms for biotechnology applications |
12/28/2000 | CA2373391A1 Spheroid preparation |
12/28/2000 | CA2373375A1 Combination of lactic acid bacteria and its use for the prevention and/or treatment of infections and inflammatory conditions |
12/27/2000 | EP1063293A2 Transforming growth factor alpha H1 |
12/27/2000 | EP1062358A1 Novel method for preparing fexofenadine |
12/27/2000 | EP1062347A1 Diagnostics and vaccines for mycobacterial infections of animals and humans |
12/27/2000 | EP1062346A1 Gene encoding labyrinthin, a marker for cancer |
12/27/2000 | EP1062224A1 Modified factor viii |
12/27/2000 | EP1062059A1 Bacterium capable of biodegradation of wastes |
12/27/2000 | EP0791070B1 Enzymatic method for detecting coliform bacteria or e. coli |
12/27/2000 | EP0671909B1 Syndecan stimulation of cellular differentiation |
12/27/2000 | EP0667099B1 Baking process |
12/27/2000 | CN1278303A Method for producing L-carnitine from crotonobetaine |
12/27/2000 | CN1278298A Alpha-amylase mutants |
12/26/2000 | US6166294 Nucleotide sequences which are expressed at preferential time during plant development for more efficient production of plant by-product |
12/26/2000 | US6166230 Sterol extraction with polar solvent to give low sterol, high triglyceride, microbial oil |
12/26/2000 | US6166193 Nucleotide sequence which encodes g-protein coupled receptor; for the treatment and prevention of bacterial, fungal, protozoan and viral infections; for use in gene therapy |
12/26/2000 | US6166185 Antibodies to human TIE-2 ligands |
12/26/2000 | US6166182 Polypeptides for the treatment of bacterial, fungal, protozoan and viral infections |
12/26/2000 | US6166180 Polypeptide for the treatment of genetic disorders associated with transmembrane protein |
12/26/2000 | US6166178 Polypeptide for the treatment of cancer; anticarcinogenic agents |
12/26/2000 | US6166176 Cancer marker protein and peptides thereof |
12/26/2000 | US6166070 Kodaistatins A, B, C and D, a process for their production and their use |
12/26/2000 | US6165992 Histidine kinase |
12/26/2000 | US6165989 An isolated polynucleotide comprising a first polynucleotide or the full complement of the entire length of the first polynucleotide, wherein the first polynucleotide encodes a polypeptide comprising specific amino acid sequence |
12/26/2000 | US6165960 Use of alkaline proteases in industrial textile laundering processes |
12/26/2000 | US6165794 Suppression of proteolytic activity by dysfunctional protease formation |
12/26/2000 | US6165777 Resolution of enantiomers of cis-1,2-dihydroxyindan compound of given formula by treating with p. putida to allow destruction of the 1r,2s-enantiomer and recovering the 1s,2r enantiomer; chemical intermediates to drugs, agrochemicals |
12/26/2000 | US6165775 Microorganism mixture having the ability to degrade cellulose, pectin and clay |
12/26/2000 | US6165765 Heat resistant enzyme from bacillus; for more accurate sequence determination using chain terminating nucleotides |
12/26/2000 | US6165762 Amino acid sequence of enzyme; drug screening of bactericides and bacteriostats; vaccines; diagnosis of infections |
12/26/2000 | US6165759 Amino acid sequence; diagnosis, prophylaxis and therapy of infections; vaccines; bacteriostats; bactericides; screening of enzyme inhibitors and activators |
12/26/2000 | US6165756 Bacterial strain of Escherichia coli BKIIM B-3996 as the producer of L-threonine |
12/26/2000 | US6165750 Streptavidin tetramers have at least one monomer containing an amino acid modification that produces a reduced binding affinity for biotin, a modified off-rate, a modified on-rate, or an altered binding enthalpy; bioseparations, drug delivery |
12/26/2000 | US6165749 Plasmid vector comprising promoter sequence to control expression of desired gene, said promoter sequence being recognized by rna polymerase derived from sp6 phage, and a replication origin for increasing copy number by induction |
12/26/2000 | US6165746 Preventing endogenous aminopeptidase mediated n-terminal amino acid cleavage during expression of foreign genes in bacteria |
12/26/2000 | US6165724 Oligonucleotides for detecting enteric hemorrhagic E.coli and detection method using the same |
12/26/2000 | US6165721 Oligonucleotides of specific nucleotide sequences; for strand displacement amplification; for hybridization probes |
12/26/2000 | US6165478 DNA encoding Chlamydia pneumoniae antigenic polypeptide |
12/26/2000 | US6165470 Hybrid macromolecules composed of albumin derivatives coupled to derivatives of the cd4 receptor having a normal or a higher affinity for the hiv-1 virus. |
12/26/2000 | US6165466 Antagonists of interleukin-15 |
12/26/2000 | US6165465 Immunologic enhancement of the somatogenic effect of somatotropin with an antibody |
12/26/2000 | US6165464 Monoclonal antibodies directed to the HER2 receptor |
12/26/2000 | US6165462 Sugar kinase |
12/26/2000 | US6165460 Generation of immune responses to prostate-specific antigen (PSA) |
12/26/2000 | CA2170322C Process for preparing sphingomyelin and ceramide from erythrocyte as a starting material and a curing agent or cosmetic formulated with ceramide |
12/26/2000 | CA2018709C Process for removing bacterial endotoxin from gram-negative polysaccharides |
12/21/2000 | WO2000077260A1 Genomic profiling: a rapid method for testing a complex biological sample for the presence of many types of organisms |
12/21/2000 | WO2000077234A2 Lycopen production method |
12/21/2000 | WO2000077233A2 Complement-resistant non-mammalian dna viruses and uses thereof |
12/21/2000 | WO2000077186A2 Bacterial protection against stress |
12/21/2000 | WO2000077035A2 Novel potassium channels and genes encoding these potassium channels |
12/21/2000 | WO2000077026A1 49 human secreted proteins |
12/21/2000 | CA2383041A1 49 human secreted proteins |
12/21/2000 | CA2375825A1 Complement-resistant non-mammalian dna viruses and uses thereof |
12/21/2000 | CA2375390A1 Genomic profiling: a rapid method for testing a complex biological sample for the presence of many types of organisms |
12/20/2000 | EP1060253A2 Modified forms of pullulanase |
12/20/2000 | EP1060240A1 New agent |
12/20/2000 | CN1277637A Method for preparing a substituted benzamide |
12/20/2000 | CN1277636A High efficiency vetroviral rectors that contain none of viral coding sequences |
12/20/2000 | CN1277207A Phytase with heat tolerance |
12/19/2000 | US6162902 Reactive to epitopes of human brain natriuretic peptide; rapid and sensitive quantification in plasma or serum |
12/19/2000 | US6162640 Selected population of host cells and/or replicators which express a molecule that undergoes a desired interaction with a recognition sequence; for efficient and rational method of controlling evolution |
12/19/2000 | US6162633 Process and kit for fragment cloning |
12/19/2000 | US6162631 Retrovirus from the HIV group and its use (MVP-2901/94) |
12/19/2000 | US6162628 Enzymatic polypeptide which retards or prevents degradation/aging of baked goods |